
First Patient Treated in Trial of PHST001 for Advanced Solid Tumors
Pheast Therapeutics announced that the first patient has been treated in a phase 1 clinical trial evaluating PHST001 in patients with advanced solid tumors, according to a news release from the company. “The start of this phase 1 trial is an important …